Vertex Pharmaceuticals
VRTX
VRTX
1,432 hedge funds and large institutions have $96.8B invested in Vertex Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 241 funds opening new positions, 556 increasing their positions, 479 reducing their positions, and 60 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,432
Holders Change
+160
Holders Change %
+12.58%
% of All Funds
20.99%
Holding in Top 10
41
Holding in Top 10 Change
+10
Holding in Top 10 Change %
+32.26%
% of All Funds
0.6%
New
241
Increased
556
Reduced
479
Closed
60
Calls
$895M
Puts
$974M
Net Calls
-$79.1M
Net Calls Change
-$120M
Top Buyers
| 1 |
Capital World Investors
Los Angeles,
California
|
+$1.56B |
| 2 |
Morgan Stanley
New York
|
+$1.26B |
| 3 |
Amundi
Paris,
France
|
+$326M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$277M |
| 5 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$157M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$562M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$528M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$392M |
| 4 |
BlackRock
New York
|
-$286M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$198M |
